Immuneering Corp Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023
Profitability
Gross Margin 44.61%44.56%50.11%
EBT Margin -737.17%-1,627.11%-15,937.29%
EBIT Margin -739.01%-1,629.17%-16,325.77%
EBITDA Margin -737.17%-1,614.68%-15,931.33%
Operating Margin -739.01%-1,629.17%-16,325.77%
Net Margin -737.17%-1,612.33%-15,937.29%
FCF Margin -634.83%-1,486.17%-14,148.44%
Efficiency
Assets Average 102.56M144.54M112.48M
Equity Average 66.75M132.92M100.21M
Invested Capital -22.48M155.98M109.85M90.58M
Asset Utilization Ratio 0.020.00
Leverage & Solvency
Equity Ratio -0.590.940.900.88
Valuation
Enterprise Value -37.09M270.26M22.54M129.46M
Market Capitalization 419.46M128.06M215.13M
Return Ratios
Return on Sales -7.37%-16.12%-159.37%
Return on Capital Employed -0.35%-0.38%-0.56%
Return on Invested Capital -0.50%
Return on Assets -0.33%-0.35%-0.49%
Return on Equity -0.50%-0.38%-0.55%